Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Sight Sciences Inc (SGHT)

Sight Sciences Inc (SGHT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 316,130
  • Shares Outstanding, K 47,826
  • Annual Sales, $ 48,960 K
  • Annual Income, $ -62,960 K
  • 60-Month Beta 0.96
  • Price/Sales 6.10
  • Price/Cash Flow N/A
  • Price/Book 1.55
Trade SGHT with:

Options Overview Details

View History
  • Implied Volatility 48.85% ( +0.53%)
  • Historical Volatility 74.50%
  • IV Percentile 4%
  • IV Rank 14.73%
  • IV High 310.96% on 05/11/22
  • IV Low 3.57% on 05/02/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 51
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 424
  • Open Int (30-Day) 401

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.47
  • Number of Estimates 4
  • High Estimate -0.44
  • Low Estimate -0.49
  • Prior Year -0.43
  • Growth Rate Est. (year over year) -9.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.98 +2.01%
on 09/19/22
7.80 -21.74%
on 08/30/22
-1.39 (-18.56%)
since 08/29/22
3-Month
5.98 +2.01%
on 09/19/22
11.81 -48.35%
on 07/06/22
-3.06 (-33.41%)
since 06/29/22
52-Week
5.98 +2.01%
on 09/19/22
27.70 -77.98%
on 11/03/21
-16.73 (-73.28%)
since 09/29/21

Most Recent Stories

More News
Sight Sciences, Inc. (SGHT) Q2 2022 Earnings Call Transcript

SGHT earnings call for the period ending June 30, 2022.

SGHT : 6.10 (-7.72%)
Why Sight Sciences (SGHT) Might Surprise This Earnings Season

Sight Sciences (SGHT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

SGHT : 6.10 (-7.72%)
Wall Street Analysts Believe Sight Sciences, Inc. (SGHT) Could Rally 121%: Here's is How to Trade

The consensus price target hints at a 121.5% upside potential for Sight Sciences, Inc. (SGHT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...

SGHT : 6.10 (-7.72%)
Quotient (QTNT) Reports Q1 Loss, Lags Revenue Estimates

Quotient (QTNT) delivered earnings and revenue surprises of -32.14% and 6.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

QTNT : 0.1500 (-10.61%)
SGHT : 6.10 (-7.72%)
Cardinal Health (CAH) to Post Q4 Earnings: What's in Store?

Cardinal Health's (CAH) fiscal fourth-quarter results are likely to reflect solid performance in the Pharmaceutical segment. However, inflation and supply chain constraints are likely to have continued....

ANGO : 20.57 (+0.83%)
CAH : 67.79 (-2.16%)
CNTA : 4.25 (-8.99%)
SGHT : 6.10 (-7.72%)
Globus Medical (GMED) Q2 Earnings and Revenues Top Estimates

Globus Medical (GMED) delivered earnings and revenue surprises of 3.70% and 2%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

GMED : 59.51 (-0.37%)
SGHT : 6.10 (-7.72%)
Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Sight Sciences, Inc. (SGHT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SGHT : 6.10 (-7.72%)
SIBN : 17.25 (-2.54%)
Inari Medical, Inc. (NARI) Reports Q2 Loss, Tops Revenue Estimates

Inari Medical, Inc. (NARI) delivered earnings and revenue surprises of 17.39% and 5.34%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

NARI : 73.96 (+1.22%)
SGHT : 6.10 (-7.72%)
Doximity (DOCS) to Report Q1 Earnings: What's in the Offing?

Doximity's (DOCS) fiscal first-quarter results are likely to reflect continued strength in its fax, e-signature and telehealth products.

BHVN : 151.53 (-0.26%)
CNTA : 4.25 (-8.99%)
DOCS : 32.00 (-1.08%)
SGHT : 6.10 (-7.72%)
Bears are Losing Control Over Sight Sciences, Inc. (SGHT), Here's Why It's a 'Buy' Now

Sight Sciences, Inc. (SGHT) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement...

SGHT : 6.10 (-7.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Sight Sciences Inc. is a medical device company. It focused on the development and commercialization of proprietary devises which target the underlying causes of prevalent eye diseases. Sight Sciences Inc. is based in MENLO PARK, Calif.

See More

Key Turning Points

3rd Resistance Point 6.92
2nd Resistance Point 6.71
1st Resistance Point 6.41
Last Price 6.10
1st Support Level 5.90
2nd Support Level 5.69
3rd Support Level 5.39

See More

52-Week High 27.70
Fibonacci 61.8% 19.40
Fibonacci 50% 16.84
Fibonacci 38.2% 14.28
Last Price 6.10
52-Week Low 5.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar